Wolfgang Miesbach: How Does Protein S Inhibition Restore Hemostasis in von Willebrand Disease?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yumiko Sakurai, published in Blood:
“How Does Protein S Inhibition Restore Hemostasis in von Willebrand Disease?
At EAHAD2026, fascinating microfluidics data from Emory University shed light on VGA039’s mechanism in VWD.
The connection isn’t immediately obvious:
VWD stems from insufficient platelet adhesion due to low or dysfunctional VWF.
Protein S is a cofactor for activated protein C, regulating thrombin generation.
Findings from the Ex Vivo Model, The haemostasis-on-a-chip data demonstrated that VGA039:
- Significantly shortened bleeding times in VWD patient blood
- Accelerated platelet deposition (p<0.004)
- Enhanced fibrin accumulation (p<0.008)
- Restored haemostasis through dual inhibition of TFPI and aPC pathways
The Mechanistic Insight:
The answer lies at the microvascular level.
By neutralizing Protein S’s dual activities (cofactor for protein C and TFPI inhibitor), VGA039 allows enhanced local thrombin generation specifically at microvascular sites – precisely where VWF normally enables platelet adhesion and where most bleeding occurs in VWD patients.
Congratulations to Yumiko Sakurai and co-authors.”
Title: A protein S-targeting monoclonal antibody, VGA039, improves both primary and secondary hemostatic activity of von Willebrand disease patient blood in an ex vivo vascularized hemostasis-on-a-chip
Authors: Yumiko Sakurai, Megan Brown, Yongzhi Qiu, Elaissa Hardy, Tony Byun, Sandip Panicker, Wilbur Lam
Read the Full Article on Blood

Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters